CURRENT Medical Diagnosis and
Treatment 2026
65th Edition
Author(s)Maxine A. Papadakis; Michael
W. Rabow; Kenneth R. McQuaid; Paul L.
Nadler; Erika Leemann Price
TEST BANK
QUESTIONS 1–5: Disease Prevention & Health Promotion
Q1 — Reference: Ch. Disease Prevention — Immunizations in
Adults
A 67-year-old with COPD has received PCV20 previously. Which
pneumococcal immunization is appropriate next?
A. PPSV23 now and every 5 years
B. No further pneumococcal vaccine required
C. Repeat PCV20 one year later
D. Single PPSV23 dose only if hospitalized
,Correct: B
Rationale: After PCV20, no additional pneumococcal vaccines
are recommended in immunocompetent adults ≥65.
Incorrects:
A: Over-immunization increases adverse effects.
C: PCV20 is not routinely repeated.
D: Not based on hospitalization status.
Teaching Point: PCV20 alone completes pneumococcal
protection in older adults.
Citation: Papadakis et al., 2026. Disease Prevention.
Q2 — Reference: Ch. Health Promotion — Screening
Recommendations
A 55-year-old woman with a 30-pack-year smoking history quit
10 years ago. Appropriate lung cancer screening?
A. Stop screening because she quit
B. Annual low-dose CT chest
C. Chest x-ray every 2 years
D. Screening only if symptoms appear
Correct: B
Teaching Point: Annual LDCT for ages 50–80 with ≥20 pack-
years who quit <15 years ago.
Citation: Papadakis et al., 2026. Health Prevention Guidelines.
Rationales omitted here for space? Nope — must include all.
Let me continue properly with full detail.
,I'll restart formatting Q2 fully:
Q2 — Reference: Ch. Health Promotion — Screening
Recommendations
A 55-year-old woman with a 30-pack-year smoking history quit
10 years ago. What screening is indicated?
A. Stop screening because she quit
B. Annual low-dose CT (LDCT) scan
C. Chest radiography every 2 years
D. Screen only with new respiratory symptoms
Correct: B
Rationale: LDCT annually reduces mortality in high-risk adults
aged 50–80 with ≥20 pack-years who quit <15 years ago.
A: Prior smoking still confers elevated risk.
C: X-rays are not sensitive for lung cancer screening.
D: Screening is proactive, not symptom-dependent.
Teaching Point: LDCT saves lives in high-risk smokers even
after cessation.
Citation: Papadakis et al., 2026. Preventive Screening.
Q3 — Reference: Ch. Disease Prevention — Cardiovascular
Risk Reduction
The most impactful lifestyle change to reduce ASCVD risk in a
smoker with hypertension?
, A. Reduce dietary sodium
B. Smoking cessation
C. Increase aerobic activity
D. Aspirin prophylaxis
Correct: B
Rationale: Smoking cessation has the greatest mortality
reduction in ASCVD.
A,C: Beneficial but not as impactful as quitting smoking.
D: Aspirin isn’t broadly indicated for primary prevention.
Teaching Point: Smoking cessation offers major immediate
ASCVD risk reduction.
Citation: Papadakis et al., 2026. Cardiovascular Prevention.
Q4 — Reference: Ch. Disease Prevention — Obesity &
Screening
A 36-year-old with BMI 34 has normal labs. Best intervention?
A. Pharmacotherapy with a GLP-1 agonist
B. Bariatric surgery referral
C. Behavioral weight management program
D. No treatment needed until metabolic disease develops
Correct: C
Rationale: Intensive lifestyle interventions are first-line in
obesity without complications.
A,B: Reserved for severe obesity or comorbidities.
D: Early prevention prevents disease progression.
Treatment 2026
65th Edition
Author(s)Maxine A. Papadakis; Michael
W. Rabow; Kenneth R. McQuaid; Paul L.
Nadler; Erika Leemann Price
TEST BANK
QUESTIONS 1–5: Disease Prevention & Health Promotion
Q1 — Reference: Ch. Disease Prevention — Immunizations in
Adults
A 67-year-old with COPD has received PCV20 previously. Which
pneumococcal immunization is appropriate next?
A. PPSV23 now and every 5 years
B. No further pneumococcal vaccine required
C. Repeat PCV20 one year later
D. Single PPSV23 dose only if hospitalized
,Correct: B
Rationale: After PCV20, no additional pneumococcal vaccines
are recommended in immunocompetent adults ≥65.
Incorrects:
A: Over-immunization increases adverse effects.
C: PCV20 is not routinely repeated.
D: Not based on hospitalization status.
Teaching Point: PCV20 alone completes pneumococcal
protection in older adults.
Citation: Papadakis et al., 2026. Disease Prevention.
Q2 — Reference: Ch. Health Promotion — Screening
Recommendations
A 55-year-old woman with a 30-pack-year smoking history quit
10 years ago. Appropriate lung cancer screening?
A. Stop screening because she quit
B. Annual low-dose CT chest
C. Chest x-ray every 2 years
D. Screening only if symptoms appear
Correct: B
Teaching Point: Annual LDCT for ages 50–80 with ≥20 pack-
years who quit <15 years ago.
Citation: Papadakis et al., 2026. Health Prevention Guidelines.
Rationales omitted here for space? Nope — must include all.
Let me continue properly with full detail.
,I'll restart formatting Q2 fully:
Q2 — Reference: Ch. Health Promotion — Screening
Recommendations
A 55-year-old woman with a 30-pack-year smoking history quit
10 years ago. What screening is indicated?
A. Stop screening because she quit
B. Annual low-dose CT (LDCT) scan
C. Chest radiography every 2 years
D. Screen only with new respiratory symptoms
Correct: B
Rationale: LDCT annually reduces mortality in high-risk adults
aged 50–80 with ≥20 pack-years who quit <15 years ago.
A: Prior smoking still confers elevated risk.
C: X-rays are not sensitive for lung cancer screening.
D: Screening is proactive, not symptom-dependent.
Teaching Point: LDCT saves lives in high-risk smokers even
after cessation.
Citation: Papadakis et al., 2026. Preventive Screening.
Q3 — Reference: Ch. Disease Prevention — Cardiovascular
Risk Reduction
The most impactful lifestyle change to reduce ASCVD risk in a
smoker with hypertension?
, A. Reduce dietary sodium
B. Smoking cessation
C. Increase aerobic activity
D. Aspirin prophylaxis
Correct: B
Rationale: Smoking cessation has the greatest mortality
reduction in ASCVD.
A,C: Beneficial but not as impactful as quitting smoking.
D: Aspirin isn’t broadly indicated for primary prevention.
Teaching Point: Smoking cessation offers major immediate
ASCVD risk reduction.
Citation: Papadakis et al., 2026. Cardiovascular Prevention.
Q4 — Reference: Ch. Disease Prevention — Obesity &
Screening
A 36-year-old with BMI 34 has normal labs. Best intervention?
A. Pharmacotherapy with a GLP-1 agonist
B. Bariatric surgery referral
C. Behavioral weight management program
D. No treatment needed until metabolic disease develops
Correct: C
Rationale: Intensive lifestyle interventions are first-line in
obesity without complications.
A,B: Reserved for severe obesity or comorbidities.
D: Early prevention prevents disease progression.
